Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 26c, Revenues Beat

August 7, 2019 7:24 AM

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.01), $0.26 better than the analyst estimate of ($0.27). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found